Examination and characterisation of the effect of amitriptyline therapy for chronic neuropathic pain on neuropeptide and proteomic constituents of human cerebrospinal fluid.

Royds, Jonathan; Cassidy, Hilary; Conroy, Melissa J; Dunne, Margaret R; Lysaght, Joanne; McCrory, Connail

Royds, Jonathan; Cassidy, Hilary; Conroy, Melissa J; Dunne, Margaret R; Lysaght, Joanne; McCrory, Connail.

Afiliación

Royds J; Department of Pain Medicine, St. James Hospital, Dublin and School of Medicine, Trinity College Dublin, Ireland.
Cassidy H; Systems Biology Ireland, School of Medicine, University College Dublin, Dublin 4, Ireland.
Conroy MJ; Department of Surgery, Trinity Translational Medicine Institute, St. James's Hospital and Trinity College Dublin, Dublin 8, Ireland.
Dunne MR; Trinity St James's Cancer Institute, St James's Hospital Dublin, Dublin 8, Ireland.
Lysaght J; Department of Surgery, Trinity Translational Medicine Institute, St. James's Hospital and Trinity College Dublin, Dublin 8, Ireland.
McCrory C; Trinity St James's Cancer Institute, St James's Hospital Dublin, Dublin 8, Ireland.

Brain Behav Immun Health ; 10: 100184, 2021 Jan.

Article en En | MEDLINE | ID: mdl-34589721

Palabras clave

Amitriptyline; Cerebrospinal fluid; Mechanism of action; Neuroimmune; Neuropathic pain; Neuropharmacology

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Brain Behav Immun Health Año: 2021 Tipo del documento: Article País de afiliación: Irlanda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google